CivaTech Oncology
Civatech is developing novel, polymer based brachytherapy devices. Our first product, the CivaString, has been granted FDA 510k clearance.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Durham, NC, USA
- Currency USD
- Founded April 2006
- Website civatechoncology.com
Company Summary
Civatech Oncology is an emerging medical device company focusing on the development of novel polymer based devices that treat cancer using localized, low-dose-rate radiation.
CivaTech's patented polymer technology enables devices that can be designed and fabricated for specific tumor types. The Company is initially targeting breast, prostate and lung cancer. The approved product is a linear source that meets existing reimbursement codes.
Team
-
Suzanne Troxler BabcockExecutive Chair
-
Seth A. Hoedl Ph.DDirector of Research and CSO
Advisors
-
Merrill Mason, Smith Anderson Blount & DorsettLawyerUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.